Previous Article | Next Article 
Infection and Immunity, September 2001, p. 5577-5588, Vol. 69, No. 9
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.9.5577-5588.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Exploitation of Interleukin-8-Induced Neutrophil
Chemotaxis by the Agent of Human Granulocytic Ehrlichiosis
Mustafa
Akkoyunlu,
Stephen E.
Malawista,
Juan
Anguita,
and
Erol
Fikrig*
Section of Rheumatology, Department of
Internal Medicine, Yale University School of Medicine, New Haven,
Connecticut 06520
Received 13 April 2001/Returned for modification 4 June
2001/Accepted 15 June 2001
 |
ABSTRACT |
The agent of human granulocytic ehrlichiosis (HGE) is an obligate
intracellular bacterium with a tropism for neutrophils; however, the
mechanisms of bacterial dissemination are not yet understood.
Interleukin-8 (IL-8) is a chemokine that induces neutrophil migration
to sites of infection for host defense against pathogens. We now show
that HGE bacteria, and the HGE-44 protein, induce IL-8 secretion in a
promyelocytic (HL-60) cell line that has been differentiated along the
neutrophil lineage with retinoic acid and in neutrophils. Infected
HL-60 cells also demonstrate upregulation of CXCR2, an IL-8 receptor,
but not CXCR1. Human neutrophils migrate towards
Ehrlichia sp.-infected cells in a chemotaxis chamber
assay, and this movement can be blocked with antibodies to IL-8.
Finally, immunocompetent and severe combined immunodeficient mice
administered CXCR2 antisera, and CXCR2
/
mice that lack
the human IL-8 receptor homologue, are much less susceptible to
granulocytic ehrlichiosis than are control animals. These results
demonstrate that HGE bacteria induce IL-8 production by host cells and,
paradoxically, appear to exploit this chemokine to enhance infection.
 |
INTRODUCTION |
Human granulocytic
ehrlichiosis (HGE) is a tick-borne infectious disease that is becoming
increasingly recognized in North America and Europe (7, 15, 24,
47). The HGE agent preferentially persists within host
neutrophils and often causes an acute febrile illness with headache,
myalgia, and cytopenias, among other symptoms (57).
Although the disease is generally self-limiting, severe complications
and fatalities have been reported elsewhere (1, 3, 21,
27). The HGE bacterium is closely related, if not identical, to
Ehrlichia equi and Ehrlichia phagocytophila,
agents of granulocytic ehrlichiosis in horses and sheep, and a workshop group has recently suggested that these organisms should be renamed Anaplasma phagocytophila, based on taxonomic considerations
(J. S. Dumler, Y. Rikihisa, G. A. Daesch, A. F. Barbet,
G. M. Palmer, and S. C. Ray, Am. Soc. Rickettsiol. 15th
Sesquiannu. Meet. Abstr. Book, p. 52, 2000). For clarity, this
pathogen will be referred to as the HGE agent or simply
Ehrlichia sp. throughout this text.
Propagation of the HGE agent in a promyelocytic (HL-60) tumor cell line
(6, 18, 32) and a murine model of granulocytic ehrlichiosis (8, 23) have increased our understanding of Ehrlichia pathogenesis. The tropism of Ehrlichia
sp. for neutrophils can be partially explained by the use of sialylated
Lewis X (CD15s) (19) and the leukocyte P-selectin
glycoprotein ligand 1 to attach to and invade polymorphonuclear
leukocytes (PMNs) (22). The persistence of
Ehrlichia sp. within membrane-bound morulae that do not fuse
with lysosomes (42, 58) and the ehrlichial suppression of
the respiratory burst (43) by downregulating
gp91phox (5) then facilitate
intracellular survival. Immunocompetent, but not severe combined
immunodeficient (SCID), mice generally clear Ehrlichia sp.
after several weeks, and Ehrlichia antisera or antibodies to
the P44 (or HGE-44) family of proteins afford partial immunity
(29, 49), demonstrating that the host response alters the
course of infection. Furthermore, gamma interferon production during
early murine infection also helps control the levels of HGE bacteria
(2, 37). Despite these advances, the mechanisms that
Ehrlichia sp. uses to attract and transfer between neutrophils in vivo are not yet known.
Chemokines are chemotactic cytokines that are classified according to
their molecular structures. Interleukin-8 (IL-8) is a potent neutrophil
attractant and a member of the
-chemokine (CXC chemokine)
family (35). Human neutrophils respond to IL-8 through CXCR1 and CXCR2 receptors. In addition to IL-8, other CXC
chemokines, including growth-related oncogene
(GRO-
),
neutrophil-activating peptide 2 (NAP-2), epithelial-cell-derived
activating peptide 78 (ENA-78), and granulocyte
colony-stimulating factor 2 (GCP-2), bind to CXCR2. Only IL-8 and
GCP-2 bind CXCR1 (35). Murine homologues of human IL-8
have not yet been identified; however, mice possess a receptor that
resembles human CXCR2 and that mediates neutrophil chemotaxis by
binding to chemokine KC or macrophage-inflammatory protein 2 (MIP-2) (9). Bacteria have been shown previously to induce
IL-8 from host cells, and this can be associated with the secretion of
proinflammatory cytokines such as tumor necrosis factor alpha
(TNF-
), IL-1
, IL-1
, or IL-17 (13, 17, 34, 53).
The importance of IL-8 in HGE infection is, however, not known. One
report recently showed that infection of HL-60 cells or human bone
marrow cells with the HGE agent induced IL-8 but not proinflammatory
cytokines (31). In contrast, others have demonstrated that
ehrlichial infection of human neutrophils induces IL-1
, TNF-
, and
IL-6 without an increase in IL-8 (30). Finally, in vivo
studies have shown that the HGE agent does not affect TNF-
and
IL-1
levels in mice or humans (37, 52).
The migration of neutrophils to the site of infection is an important
first-line defense against bacteria, resulting in phagocytosis and
microbial eradication. Nevertheless, neutrophil-specific
receptor-mediated adhesion (19, 22), lysosomal evasion
(32, 58), and NADPH oxidase repression (5,
43) help the HGE agent to invade and persist within cells.
Therefore, recruitment of neutrophils to the location of
Ehrlichia infection may paradoxically facilitate dissemination, rather than elimination, of this bacterium. We have now
investigated the influence of the HGE agent on host cell IL-8 secretion
and its role in Ehrlichia pathogenesis.
 |
MATERIALS AND METHODS |
Cultivation of the HGE agent.
The HGE isolate NCH-1
(50) was cultured in HL-60 cells (240-CCL; American Type
Culture Collection, Manassas, Va.) grown in Iscove's modified
Dulbecco's medium (Gibco BRL, Life Technologies, Grand Island, N.Y.)
supplemented with 20% fetal calf serum (FCS) at 37°C with 5%
CO2. To induce neutrophilic differentiation,
HL-60 cells (2 × 106 cells/ml) were
incubated with 1 µM retinoic acid for 4 days. Differentiated HL-60
cells were designated rHL-60 cells. Infection of rHL-60 cells was
effected by adding 105 Ehrlichia
sp.-infected HL-60 cells (over 75% of the cells were infected with the
HGE agent) to rHL-60 cells.
SCID mice develop a persistent infection with the HGE agent, and blood
from these animals can also be used to uniformly infect naive mice
(2). One hundred microliters of blood from
Ehrlichia sp.-infected SCID mice was therefore used to
challenge inbred immunocompetent BALB/c, C3H-scid, or IL-8
receptor-deficient (CXCR2
/
) mice with the HGE
agent. C3H-scid mice were obtained from the Frederick Cancer
Research Center (Frederick, Md.) and initially challenged with
Ehrlichia sp. by intraperitoneal (i.p.) injection of 100 µl of Ehrlichia sp.-infected HL-60 cells. Blood from
infected SCID mice with morulae in 8% of the peripheral neutrophils
was then used for infection
instead of infected HL-60 cell culture
to avoid the possible antigenic influence of human cells introduced into
the mice.
In vitro infection of human neutrophils and mouse splenocytes
with Ehrlichia sp.
Human neutrophils were isolated
from 10 ml of fresh human blood drawn in tubes containing 0.25 ml of
anticoagulant (1,000 U of heparin/ml). Blood was mixed with 3% dextran
at a 1:3 (blood-to-dextran) ratio and incubated for 30 min at room
temperature. The supernatant containing PMNs was collected and
centrifuged at 750 × g for 10 min at room temperature.
The supernatant was then discarded, and 5 ml of Kreb's-Ringer's
phosphate-buffered solution with glucose was added in resuspending the
cells. Residual red blood cells were removed by hypotonic lysis and
centrifugation at 4°C. After three washings with Kreb's-Ringer's
phosphate-buffered solution with glucose, 2 × 106 cells/ml were incubated with isolated
Ehrlichia sp. Splenocytes isolated from uninfected BALB/c
mice were washed with Hanks' balanced salt solution (Gibco BRL)
containing 10% FCS and suspended at 6 × 106 cells/ml in six-well culture plates (Corning,
Corning, N.Y.). Ehrlichias were isolated from 10 ml of infected HL-60
cells (106 cells/ml) that were mechanically lysed
by multiple passages through a 251/2-gauge needle. Ten
milliliters of uninfected HL-60 cells (106
cells/ml) was treated the same way to obtain HL-60 cell products that
would be used as controls. Disrupted HL-60 cell suspensions were
centrifuged at 750 × g for 10 min to spin down
unbroken HL-60 cells. Free ehrlichias were collected by centrifuging
the supernatants at 2,300 × g for 10 min at 4°C.
Free ehrlichias were suspended in phosphate-buffered saline (PBS), pH
7.4, and washed twice before resuspending the pellets in 4 ml of
Hanks' balanced salt solution containing 10% FCS. Ehrlichias were
added to 2 × 106 human PMNs or 6 × 106 mouse splenocytes suspended in 1 ml of
Hanks' balanced salt solution (Gibco BRL) containing 10% FCS.
Ehrlichias were incubated with human PMNs or mouse splenocytes in
six-well culture flasks for up to 24 h at 37°C with 5%
CO2.
Measurement of culture supernatant and chemokines and cytokines
in serum.
Culture supernatant and serum or peritoneal lavage
cytokine and chemokine levels were measured using a sandwich
enzyme-linked immunosorbent assay (ELISA). Biotin-labeled and unlabeled
goat antibodies against human GRO-
, IL-8, IL-1
, IL-1
, TNF-
,
and IL-17 and mouse KC and MIP-2 were purchased from Pharmingen (San Diego, Calif.) and R&D Laboratories (Minneapolis, Minn.). Recombinant human GRO-
, IL-8, IL-1
, IL-1
, TNF-
, NAP-2, ENA-78, IL-17, and GCP-2 and mouse KC and MIP-2 were used to plot a standard curve for
each cytokine or chemokine. Antibody-coated ELISA plates were blocked
with 200 µl of 1.5% bovine serum albumin in PBS (blocking buffer)
for 2 h at room temperature. Serially diluted culture supernatants
or sera were applied to the wells and incubated for 4 h at room
temperature. Known concentrations of recombinant cytokines or
chemokines were also included to develop standard curves for ELISA.
Wells were washed with 0.05% Tween 20 in PBS before adding 100 µl of
biotinylated antibodies, diluted 1:4,000, in blocking buffer. Following
incubation for 45 min at room temperature, 1:1,000-diluted peroxidase-conjugated streptavidin (Bio-Rad Laboratories, Hercules, Calif.) was used to detect bound antibodies. Peroxidase developing solution (Kirkegaard & Perry Laboratories, Gaithersburg, Md.) was used
to induce the chromogenic reaction of peroxidase, and the resulting
absorbency was read at 450 nm following the addition of stop
solution (Kirkegaard & Perry Laboratories).
Human serum samples.
Stored human sera, collected from
patients with HGE during an active surveillance study designed to
assess the incidence of HGE in a 12-town area in Connecticut
(24), were used to examine IL-8 levels during
ehrlichiosis. Sera were obtained from patients with confirmed cases of
HGE in which the patients had fevers, headache, and/or myalgia and were
PCR positive for Ehrlichia sp. Control sera were from
healthy volunteers and from individuals in the surveillance study with
fever and/or myalgia but without serologic or PCR evidence of HGE.
Detection of IL-8 was performed in an ELISA as described above.
Determination of IL-8 mRNA in rHL-60 cells.
Ehrlichia sp.-infected and uninfected rHL-60 cells were
harvested, and total RNA was extracted by using the Stratagene (La Jolla, Calif.) RNA isolation kit. The ProSTAR first-strand reverse transcription-PCR kit (Stratagene) was used to reverse
transcribe 5 µg of RNA in a 50-µl reaction mixture. IL-8-specific
primers 5'-ATG ACT TCC AAG CTG GCC GTG GCT-3' and
5'-TCT CAG CCT TCT TCA AAA ACT TCT C-3' were used to amplify
IL-8 cDNA. Hypoxanthine-guanine phosphoribosyltransferase (HPRT)
primers were used to assess and normalize the cDNA concentrations among
samples from Ehrlichia sp.-infected and uninfected HL-60 cells.
Measurement of IL-8 receptor expression.
The levels of
infected and uninfected HL-60 cell IL-8 receptors CXCR1 and CXCR2 were
analyzed by flow cytometry. Retinoic acid-treated HL-60 cells (rHL-60
cells; 6 × 106) were incubated for 5 days
with 6 × 105 infected HL-60 cells.
Fluorescein-conjugated monoclonal antibody to human CXCR1 (Pharmingen)
and R-phycoerythrin-conjugated CXCR2 (Pharmingen) were
incubated with 106 Ehrlichia
sp.-infected or uninfected control rHL-60 cells suspended in
10% FCS in PBS. Biotin-labeled mouse immunoglobulin G1 (IgG1) and
IgG2b antibodies (Pharmingen) were used as isotype-specific control
immunoglobulins. Surface-bound antibodies were detected by
fluorescence-activated cell sorting analysis.
Neutrophil chemotaxis assay.
Freshly isolated PMNs (2.4 × 106) suspended in 50 µl of Hanks' balanced
salt solution (Gibco) were added to the upper compartment of a 96-well
ChemoTx System chemotaxis chamber (Neuro Probe, Inc., Gaithersburg,
Md.). Three hundred microliters of culture supernatants or recombinant
IL-8 (Pharmingen), at 350 ng/ml, was added to the lower compartment.
Ehrlichia sp.-infected cell culture supernatant contained
276 ng of IL-8/ml, and uninfected HL-60 cell culture supernatant
contained 12 ng of IL-8/ml. After 30 min of incubation at 37°C with
5% CO2, cells that did not migrate were rinsed
from the upper compartment of a 3-µm-pore-size filter. Cells attached under the filter were released by washing the filters with PBS containing 2 mM EDTA and by centrifugation. The migrated live cells in
the wells were quantified by reading the absorbency at 490 nm following
the addition of 20 µl of CellTiter 96 AQueus assay reagent (Promega,
Madison, Wis.). To assess the role of IL-8 in the induction of
chemotaxis, neutralizing monoclonal antibodies to human IL-8 (R&D
Laboratories) were added to the lower compartment of the chamber at a
concentration of 20 µg/ml. Uninfected pooled murine sera were used as
negative controls. Control wells containing serially diluted cells were
also treated with 20 µl of CellTiter 96 AQueus assay reagent to
obtain a standard curve of optical density readings. The optical
density values of the samples were expressed relative to the standard
curve values, yielding an index of cells that migrated across the membrane.
Infection of mice with the HGE agent.
Both the BALB/c mice
and IL-8 receptor (CXCR2
/
) knockout mice
(BALB/c-Cmkar2tm1Mwm) were obtained from
the Jackson Laboratories (Bar Harbor, Maine). C3H-scid mice
were purchased from the Frederick Cancer Research Center. HGE was
induced in three BALB/c and three CXCR2
/
mice
by i.p. injection of 100 µl of ehrlichia-containing blood from donor
SCID mice (2). EDTA-treated peripheral blood and sera were
collected from each mouse on days 2, 7, 15, and 30. Bacterial infection
was assessed by determining the percentage of ehrlichia-containing
(morulae) cells among at least 200 granulocytes examined in each
peripheral blood smear. Slides were stained with Diff-Quick (Baxter
Healthcare Corp., Miami, Fla.) and examined for morulae by light
microscopy. The donor mice had morulae in 8% of the peripheral
neutrophils. All mice were maintained in barrier-filtered cages,
received a standard laboratory diet, and were given water ad libitum.
One hundred microliters of peripheral blood collected in anticoagulant
(1 mM EDTA) was incubated twice with 900 µl of erythrocyte lysis
buffer (155 mM NH4Cl, 10 mM
KHCO3, 1 mM EDTA) prior to extraction of blood
DNA. Cells deprived of erythrocytes were suspended in 200 µl of PBS,
pH 7.2, and DNA was extracted with the QIAamp tissue kit (Qiagen Inc.,
Valencia, Calif.) according to the manufacturer's instructions. PCR
amplification of HGE agent DNA was done by using 16S ribosomal DNA
primers detecting the bp 497 to 521 (5'-TGT AGG CGG CGG TTC GGT
AAG TTA AAG-3') and bp 747 to 727 (5'-GCA CTC ATC GTT TAC
AGC GTG-3') regions. Pooled DNA samples were subjected to PCR
amplification using HPRT primers, and DNA from each group was equalized
prior to Ehrlichia PCR amplification. Blood
Ehrlichia DNA was also assessed by using a quantitative
competitive PCR method as described previously (2).
Briefly, predetermined increasing amounts of a competitor DNA fragment
with external Ehrlichia primers were mixed with a series of
tubes containing a constant amount of target mouse blood DNA in a
50-µl PCR mixture. Specific primers for Ehrlichia 16S
ribosomal DNA were added to the reaction mix, and the DNA was allowed
to compete with the competitor DNA for the primers in a thermal cycler
(MJ Research, Inc., Waltham, Mass.). Amplified products were run on a
2% agarose gel, and ethidium bromide-stained gels were analyzed for
the PCR band intensity where the competitor and Ehrlichia
DNA molecules were equivalent. At this point, the Ehrlichia
DNA concentration was considered equal to the competitor DNA
concentration since they both competed for the same primers.
Experiments were repeated at least twice.
The effect of in vivo inhibition of CXCR2 on Ehrlichia
infection was investigated by using neutralizing antisera to murine CXCR2 (a kind gift of R. Strieter, UCLA School of Medicine). Normal goat serum (NGS) (Sigma Biochemicals) was used as a control antibody. The effect of CXCR2 antisera was tested with BALB/c mice and
C3H-scid mice. BALB/c mice were used because this is the
strain on which the CXCR2
/
mice were
generated. C3H-scid mice were assessed because infection with the HGE agent has been extensively studied with these animals, and
the scid mutation results in a more severe infection
(2, 23, 49). Groups of three mice were injected i.p. with
500 µl of CXCR2 antisera or NGS 2 h prior to challenge with
ehrlichia-containing SCID mouse blood. Mice were injected with the same
amount of antisera two more times, on days 2 and 4 of infection. On day
7, blood samples of control and test animals were analyzed for
Ehrlichia burden by PCR and for the percentage of peripheral
neutrophils with morulae.
The effect of CXCR2 antiserum on mice that had been previously infected
with Ehrlichia sp. was also explored. Eight mice were inoculated with ehrlichias as described above. The level of infection was determined 10 days after bacterial challenge by counting the peripheral neutrophils with morulae. Four mice were then injected (i.p.) with 500 µl of CXCR2 antisera four times at 36-h intervals. The remaining four mice (controls) received the same amount of NGS.
Ehrlichia infections were compared before and after
treatment with CXCR2 antisera.
Analysis of neutrophil chemoattraction to the site of
Ehrlichia inoculation.
To explore the in vivo
effect of Ehrlichia sp. on the chemoattraction of
neutrophils, three BALB/c mice were i.p. infected with
Ehrlichia sp. as described above. Four hours after bacterial challenge, mice were euthanatized with CO2
inhalation and the peritoneal cells were harvested by lavage. Three
milliliters of sterile PBS was injected into the peritoneal cavity. The
injected fluid was dispersed throughout the cavity and was recovered
using a syringe. Lavage fluids from three animals were pooled, and
cells were collected by centrifugation at 300 × g.
Supernatant KC and MIP-2 levels were determined in an ELISA. The number
of neutrophils in the lavage material was assessed by flow cytometry by
using fluorescein isothiocyanate-labeled anti-Gr-1 antibodies
(Pharmingen). Flow cytometry was performed as described above.
Background peritoneal neutrophil counts were done with three naive mice
that did not receive an Ehrlichia inoculum. To address the
role of CXCR2 in Ehrlichia sp.-induced in vivo neutrophil
migration, groups of three mice were administered (i.p.) 500 µl of
CXCR2 antisera or NGS 2 h before bacterial challenge. Four hours
later, peritoneal neutrophil counts were performed as described above.
Experiments were repeated at least twice.
Measurement of antibodies against Ehrlichia
antigens.
IgG antibodies to Ehrlichia sp. were measured
by ELISA in Ehrlichia sp.-challenged
CXCR2
/
and wild-type BALB/c mice.
Ehrlichia bacteria were purified from HL-60 cells as
described above and kept at
20°C until use in ELISA. Wells were
coated with 100 ng of ehrlichias/well and blocked with 1.5% bovine
serum albumin in PBS. Serially diluted serum samples were added to
wells and incubated for 4 h. Wells were washed with washing
buffer, and peroxidase-labeled goat anti-mouse IgG antibodies (Sigma)
diluted 1:4,000 in 0.05% Tween 20-containing blocking buffer were
added. After 1 h of incubation and washing, the chromogenic
reaction was induced by adding peroxidase developing solution
(Kirkegaard & Perry Laboratories). The reaction was terminated using
stop solution (Kirkegaard & Perry Laboratories), and the absorbency was
read at 450 nm.
Statistical methods.
Data are presented as the means ± standard errors. In figures where the results of two experiments are
shown, at least three replicates were included in each experiment.
Comparisons between the means of controls and those of infected
replicates were made by the two-sample Student t test.
P values of <0.05 were considered significant.
 |
RESULTS |
IL-8 secretion and IL-8 mRNA expression by Ehrlichia
sp.-infected HL-60 cells.
IL-8 is a potent
chemokine that induces neutrophil chemotaxis and could play a role in
enabling Ehrlichia sp. to maintain infection in PMNs or in
their precursors. We examined the effect of Ehrlichia sp. on
the induction of IL-8 in undifferentiated HL-60 cells and HL-60 cells
that had been terminally differentiated along the neutrophil lineage
with retinoic acid. Levels of TNF-
, IL-1
, and IL-1
were also
examined, since these proinflammatory cytokines may induce IL-8
secretion (14, 38). IL-8, TNF-
, IL-1
, and IL-1
were not detectable in culture supernatants of undifferentiated control
HL-60 cells or Ehrlichia sp.-infected undifferentiated HL-60
cells at 6 days (Fig. 1A, columns a and b). Furthermore, uninfected (control) or infected HL-60 cells that were
differentiated with retinoic acid did not have statistically different
levels (P > 0.05) of these molecules (Fig. 1A, columns c and d). The interaction of Ehrlichia sp. with molecules
that are expressed after treatment of HL-60 cells with retinoic acid may be important in secretion of cytokines and chemokines. Therefore, experiments were performed in which HL-60 cells were first
differentiated with retinoic acid (rHL-60) and then incubated with
HL-60 cells alone (control) or ehrlichia-containing HL-60 cells (Fig.
1A, columns e and f). In contrast to the previous results, HGE bacteria induced high levels of IL-8 (P < 0.0001) in rHL-60
cells (Fig. 1A, column f). TNF-
, IL-1
, and IL-1
were not
detected.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 1.
IL-8 and inflammatory cytokine secretion by HL-60 cells
in response to Ehrlichia sp. (A) In columns a to d,
2 × 106 undifferentiated HL-60 cells were given
105 HL-60 cells (control) (a and c) or 105
Ehrlichia sp.-infected HL-60 cells (b and d). In columns
c and d, the cells were subsequently treated with retinoic acid. In
columns e and f, 2 × 106 HL-60 cells were first
treated with retinoic acid (rHL-60) and then administered
105 uninfected HL-60 cells (e) or Ehrlichia
sp.-infected HL-60 cells (f). In each case, 6 days after the additions,
culture supernatants were assayed for IL-8, IL-1 , IL-1 , and
TNF- . The means ± standard errors of triplicate samples are
presented. Results from one of two similar experiments are shown. (B)
IL-8 mRNA expression was determined at 12 and 72 h after exposure
of 2 × 106 rHL-60 cells to 105
Ehrlichia sp.-infected HL-60 cells (+).
rHL-60 cells (2 × 106) exposed to 105
HL-60 cells served as a control ( ). All samples demonstrated
equivalent levels of HPRT mRNA (control). Results from one of three
representative studies are shown.
|
|
IL-8 mRNA was then examined in Ehrlichia sp.-infected and
uninfected rHL-60 cells to further explore the increased IL-8 levels. Reverse transcription-PCR was performed, and mRNA was measured at 12 and 72 h after the addition of 105 infected
or uninfected HL-60 cells to 2 × 106 rHL-60
cells. At 72 h, Ehrlichia sp.-infected rHL-60 cells had strong expression of IL-8 mRNA, while uninfected rHL-60 cells manifested a faint band that can barely be seen on the gel (Fig. 1B).
Kinetics of IL-8 secretion from Ehrlichia
sp.-infected rHL-60 cells.
In order to determine the kinetics of
Ehrlichia sp.-induced IL-8 secretion from rHL-60
cells, culture supernatants were collected at seven time points (1 to
120 h) after the addition of Ehrlichia sp.-infected HL-60 cells to rHL-60 cells. A significant
increase in IL-8 concentration was detected 24 h after addition of
the HGE agent (P < 0.01), compared to the
concentration at 12 h. IL-8 levels then continued to increase
until the last time point tested, 120 h (Fig.
2A).

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 2.
Kinetics of IL-8 secretion from Ehrlichia
sp.-infected rHL-60 cells and the effect of the amount of ehrlichias on
IL-8 secretion. (A) IL-8 levels were measured until 5 days after the
addition of 105 Ehrlichia
sp.-infected or uninfected (control) HL-60 cells to
2 × 106 rHL-60 cells. The means ± standard
errors of three experiments are shown. (B) Culture supernatant IL-8
levels after the addition of 105, 104, or
103 Ehrlichia sp.-infected HL-60 cells or
105 uninfected (control) HL-60 cells to rHL-60 cells. The
means ± standard errors of three experiments are shown.
|
|
We then assessed the influence of the Ehrlichia inoculum
size on the induction of IL-8 from rHL-60 cells. Ehrlichia
sp.-infected HL-60 cells (103,
104, or 105) were added to
2 × 106 rHL-60 cells. The secretion of IL-8
was dependent on the relative amount of HGE bacteria. rHL-60 cells
inoculated with 105 Ehrlichia
sp.-infected HL-60 cells had much higher levels of IL-8 (523 ng/ml) than did rHL-60 cells inoculated with 104
(146 ng/ml) or 103 (105 ng/ml)
Ehrlichia sp.-infected HL-60 cells (Fig. 2B). All these values were significantly higher (P < 0.05) than
those in control studies in which rHL-60 cells were exposed to
uninfected (control) HL-60 cells (46.5 ng/ml).
Induction of IL-8 from rHL-60 cells and neutrophils by HGE-44, a
major 44-kDa antigen on the HGE agent.
A group of genes designated
the HGE-44 (or P44) gene family encode a large number of proteins that
elicit prominent immune responses during early infection (25, 45,
61, 62). HGE-44 and P44 are individual proteins that are
expressed by members of this gene cluster (25, 61, 62).
These antigens may play roles in immunity and pathogenesis because
monoclonal antibodies to P44 partially protect mice from infection
(29), and electron microscopy demonstrates that these
antibodies bind the surface of morulae (29). The HGE-44
antigen has been expressed and purified elsewhere as a recombinant
fusion protein with maltose-binding protein (MBP) (26). In
order to assess the role of HGE-44 in IL-8 secretion, increasing
concentrations of HGE-44-MBP fusion protein were incubated with rHL-60
cells or human neutrophils. As a control, rHL-60 cells were exposed to
recombinant MBP that had been made in the identical fashion as the
HGE-44-MBP protein. After 5 days of incubation, culture supernatants
of rHL-60 cells containing HGE-44-MBP had a dose-dependent induction
of IL-8 that was markedly higher at 500 (P < 0.01),
1,000 (P < 0.001), and 2,000 (P < 0.0001) ng/ml than that of rHL-60 cells incubated with MBP (Fig.
3A). IL-8 secretion by human PMNs was
determined after 12 h of incubation with HGE-44-MBP or MBP
(control) alone. Neutrophils that were incubated with HGE-44-MBP
secreted higher levels (P < 0.02) of IL-8 than did
controls (Fig. 3B).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 3.
The effect of HGE-44 on the induction of IL-8 from
rHL-60 cells and PMNs. (A) rHL-60 cells were incubated with increasing
concentrations of HGE-44-MBP fusion protein or MBP (control), and
culture supernatant IL-8 levels were measured 5 days later. The molar
ratio of HGE-44 to MBP in HGE-44-MBP fusion protein is approximately
2:3. Results from one of two experiments with similar results are shown
as means ± standard errors. (B) PMNs were incubated with
increasing concentrations of HGE-44-MBP fusion protein or MBP
(control), and culture supernatant IL-8 levels were measured 24 h
later. The results of three independent experiments are expressed as
means ± standard errors.
|
|
IL-8 receptor CXCR2 expression in Ehrlichia
sp.-infected rHL-60 cells.
Levels of the cell surface IL-8
receptors CXCR1 and CXCR2 were then examined by flow cytometry to
determine whether infection with HGE bacteria alters receptor
expression. rHL-60 cells incubated with Ehrlichia
sp.-infected cells or control cells were analyzed 5 days after the
onset of infection. The expression of CXCR2 was upregulated in cultures
containing Ehrlichia sp. compared to that of uninfected
rHL-60 cells. In contrast, CXCR1 expression was not affected. Results
of a representative experiment are shown in Fig.
4. Since CXCR2 is a receptor for other
ligands such as GRO-
, NAP-2, ENA-78, and GCP-2 (10,
36), we determined the levels of these molecules in the culture
supernatants of Ehrlichia sp.-infected rHL-60 cells and
found that they were not increased (data not shown).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 4.
Flow cytometric analysis of IL-8 receptors CXCR1 and
CXCR2 on rHL-60 cells. rHL-60 cells (106) that were
infected with Ehrlichia sp. (solid gray line) or
incubated with HL-60 cells (black dashed line) were analyzed for
surface expression of CXCR1 and CXCR2. Results of one of three
representative experiments are shown.
|
|
Induction of IL-8 secretion from Ehrlichia
sp.-infected human neutrophils.
Studies with ehrlichias and human
neutrophils were then performed to extend our observations beyond HL-60
cells. Incubation of isolated ehrlichias with human PMNs resulted in
the induction of IL-8 secretion. By 7 and 24 h, IL-8 levels
increased to 10.5 and 40 ng/ml, respectively (Fig.
5), in the infected PMN cultures, which
were higher at both time points (P < 0.001 and
P < 0.0001, respectively) than were controls. None of
the other cytokines and chemokines tested, including IL-1
, IL-1
,
TNF-
, IL-17, GRO-
, NAP-2, ENA-78, and GCP-2, increased after
Ehrlichia infection (data not shown). Culture supernatant
IL-8 levels were not measured after 24 h, as the viability of PMNs
diminished significantly after this time point.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 5.
IL-8 secretion by human neutrophils in response to the
HGE agent. IL-8 levels were measured at 2, 7, and 24 h following
infection of human PMNs with isolated ehrlichias. The means ± standard errors of three studies are shown.
|
|
Chemotactic activity of culture supernatants from
Ehrlichia sp.-infected cells.
The
functional effect of IL-8 induction by the HGE agent was examined using
a chemotaxis assay to help determine its role in Ehrlichia
pathogenesis. Freshly isolated human neutrophils were incubated with
culture supernatants from Ehrlichia sp.-infected or uninfected (control) rHL-60 cells. Recombinant IL-8 served as the
positive control. The effect of the Ehrlichia
sp.-infected rHL-60 culture supernatants on the migration of
neutrophils was comparable to that of recombinant (350 µg/ml) IL-8
(P < 0.001, compared with no antibody) (Fig.
6). In contrast, uninfected rHL-60 cell
culture supernatant did not induce chemotaxis (Fig. 6). In order to
assess the contribution of Ehrlichia sp.-induced
IL-8 to neutrophil migration, we then performed blocking experiments using neutralizing antibodies against IL-8. Twenty micrograms of IL-8
antibody per milliliter prevented the neutrophil migration induced by
Ehrlichia sp.-infected cell culture supernatant
or recombinant IL-8 (control), indicating that IL-8 was the major contributor to the chemotaxis induced by the HGE agent (P
<0.001). Sera from normal mice had no effect.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 6.
Measurement of chemotaxis-induced
Ehrlichia sp.-infected rHL-60 cell culture supernatants
and the effect of neutralizing antibodies to IL-8 on chemotaxis.
Culture supernatants from infected and uninfected rHL-60 cells were
used as chemoattractants in 96-well Neuro Probe TX chambers together
with recombinant IL-8 (20 µg/ml) as a positive control and medium as
a negative control. In other wells, mouse anti-human IL-8 monoclonal
antibodies or normal murine sera (negative control) were added to
culture supernatants to determine the effect of neutralizing antibodies
to IL-8 on chemotaxis. Migrated cells were determined by optical
density reading after the addition of a tetrazolium compound as
a color development reagent. Readings recorded with medium alone were
considered as background, and the migration index was calculated after
the subtraction of background values. The means ± standard errors
of three independent studies are shown. Ab, antibody.
|
|
Ehrlichia sp. induces neutrophil chemotactic
molecules in mice.
Although mice have a homologue of the human
CXCR2 receptor, the murine equivalent of IL-8 has not yet been
identified. Nevertheless, murine MIP-2 and KC have been shown to bind
CXCR2 and facilitate neutrophil chemotaxis. Therefore, the ability of
Ehrlichia sp. to stimulate these molecules was assessed.
Splenocytes from BALB/c mice were incubated with free ehrlichias. After
24 h of incubation, culture supernatants of infected mouse
splenocytes contained significantly higher amounts of MIP-2
(P < 0.001) and KC (P < 0.002) (Fig.
7) than did controls. These experiments
demonstrate that, following Ehrlichia infection, mice
secrete high levels of neutrophil chemotactic molecules that are known
to bind CXCR2.

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 7.
Levels of the murine neutrophil chemokines, MIP-2 and
KC, from splenocytes exposed to Ehrlichia sp.
Splenocytes from BALB/c mice were incubated for 24 h with free
ehrlichias that were extracted from infected HL-60 cells or
supernatants from uninfected HL-60 cells that were treated in an
identical fashion (control). The means ± standard errors of three
studies are shown.
|
|
HGE infection in CXCR2
/
mice and mice treated with
CXCR2 antiserum.
To explore the importance of CXCR2-induced
migration of neutrophils for granulocytic ehrlichiosis, we infected
CXCR2
/
mice generated on a BALB/c background
and wild-type BALB/c mice (controls) with the HGE agent. Control mice
manifested infection kinetics similar to those of C3H and B6 mice that
have been reported earlier (2, 23, 49). The bloodstream
infection peaked at approximately 1 week and cleared by 3 weeks.
Ehrlichia infection was markedly diminished in the
CXCR2
/
mice. All three
CXCR2
/
mice had lower numbers of infected
neutrophils than did the control mice at the peak of infection (day 7).
On day 7, the percentages of neutrophils with morulae were 4.5, 8, and
6.5 in the three BALB/c mice and 2, 0, and 1.5 in the three
CXCR2
/
mice. The mean number of morulae in
the three CXCR2
/
mice was significantly lower
(P < 0.01) than that in the wild-type BALB/c mice
(Fig. 8A). The difference in the morulae
counts between the two groups of mice was also reflected in the blood
Ehrlichia DNA profiles. On day 7, representing the peak
infection, the Ehrlichia DNA concentration in pooled DNA
from the BALB/c mice was higher than that in the
CXCR2
/
mice (Fig. 8B). In accordance with the
decreased bacterial load in CXCR2
/
mice, a
serum ELISA performed on day 28 showed that
CXCR2
/
mice also had significantly
(P < 0.002) lower levels of mean serum IgG antibodies
to Ehrlichia sp. than did BALB/c mice (Fig. 8C).

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 8.
Ehrlichiosis in CXCR2 / mice. (A) Groups
of three mice were infected with the HGE agent, and the percentage of
peripheral neutrophils with morulae containing ehrlichias was assessed.
(B) DNA was extracted from the peripheral blood of
Ehrlichia sp.-infected CXCR2 / and BALB/c
mice (n = 3). In the representative experiment
shown, Ehrlichia DNA was quantified using a competitive
PCR construct. As a control, HPRT DNA was amplified in all cases. (C)
Anti-Ehrlichia sp. IgG antibody levels in
CXCR2 / and BALB/c mice. The means ± standard
errors of two groups of three mice are shown.
|
|
To extend these observations, BALB/c mice and C3H-scid mice
were administered CXCR2 antisera and then challenged with
Ehrlichia sp. BALB/c mice were used because they represent
the same background that was used to generate the
CXCR2
/
mice. C3H-scid mice were
used because these animals have previously been shown to develop a
persistent infection with the HGE agent (23). BALB/c and
C3H-scid mice that received CXCR2 antisera had significantly
lower levels of Ehrlichia infection than did mice that were
given control antiserum (NGS). On day 7, the mean Ehrlichia
DNA concentration in CXCR2 antiserum-treated BALB/c mice was 8.7 ng/ml
while control BALB/c mice had 71 ng/ml (P < 0.015)
(Fig. 9A). On the same day, the mean
Ehrlichia DNA concentration of three CXCR2 antiserum-treated
C3H-scid mice was 3 ng/ml compared to 76 ng/ml for the three
control C3H-scid mice (P < 0.001).
Furthermore, the mean percentage of neutrophils with morulae was lower
(P < 0.025) in CXCR2 antiserum-treated BALB/c mice
(0.6%) than it was in controls (3.6%) (Fig. 9B). Similarly, CXCR
antiserum-treated C3H-scid mice also had fewer morulae than
did control animals (P < 0.02). In vivo treatment of
mice with CXCR2 antisera did not result in a significant change in the
systemic neutrophil count (data not shown).

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 9.
Ehrlichia DNA concentrations in BALB/c
and C3H-scid mice that were administered CXCR2 antisera.
Control mice were given NGS. DNA levels were measured on day 7, the
peak of infection. (A) Mouse blood DNA was quantified by quantitative
PCR using a competitor construct, as described in Materials and
Methods. (B) The mean percentage of peripheral neutrophils with
ehrlichia-containing morulae is seen in mice administered CXCR2
antisera or control. The means ± standard errors obtained for
three mice in each group are shown. Results of one of two
representative experiments are presented.
|
|
We next explored whether the inhibition of neutrophil migration
following (rather than prior to) challenge with Ehrlichia sp. would alter infection. For this purpose, eight C3H-scid
mice were i.p. infected with Ehrlichia sp., and 10 days
later, groups of four mice were given three doses of CXCR2 antiserum or
control serum (NGS) every 36 h. The level of infection was
monitored by determining the number of neutrophils with morulae and PCR
amplification of blood Ehrlichia DNA, before and after
injections of antisera. In contrast to CXCR2
/
mice or mice that received CXCR2 antisera prior to Ehrlichia challenge, administration of CXCR2 antisera to previously infected mice
did not modify the level of infection. The mean percentages of
neutrophils containing morulae on days 0, 2, and 5 after antiserum administration were 8.8, 6.8 (P = 0.1 compared to day
0), and 7.3 (P = 0.2 compared to day 0), respectively
(Fig. 10A). The mean blood
Ehrlichia DNA concentration values for the same days were 117, 91.3 (P = 0.1 compared to day 0), and 114 (P = 0.4 compared to day 0) ng/ml, respectively (Fig.
10B). As expected, control sera did not affect the level of infection.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 10.
The effect of CXCR2 antisera on HGE infection in
C3H-scid mice previously infected with
Ehrlichia sp. Ten days after the inoculation of
C3H-scid mice with Ehrlichia sp., CXCR2
antisera or control sera were administered i.p., the
Ehrlichia DNA content was assessed by semiquantitative
PCR (A), and the percentage of peripheral blood neutrophils containing
morulae was determined (B). Values obtained for four mice in each group
are expressed as means ± standard errors. Results from one of two
experiments with similar results are shown.
|
|
Assessment of in vivo neutrophil chemotaxis induced by
Ehrlichia sp.
To further examine whether
Ehrlichia sp. induces the chemoattraction of neutrophils in
vivo, we analyzed the neutrophil counts in lavage fluid after injection
of ehrlichias into the murine peritoneal cavity. At 4 h after the
inoculation of ehrlichias, the influx of neutrophils into the
peritoneal cavity was readily detected by flow cytometry by using
anti-Gr-1 antibodies (Fig. 11).
Ehrlichia sp.-induced neutrophil migration to the peritoneal cavity was significantly decreased when CXCR2 antisera were injected prior to Ehrlichia inoculation (Fig. 11). Injection of
control antisera did not inhibit the migration of neutrophils to the
peritoneal cavity following Ehrlichia inoculation.
Peritoneal lavage fluid from Ehrlichia sp.-inoculated mice
also contained higher KC and MIP-2 levels than did fluid from control
mice that received blood from uninfected C3H-scid mice. The
levels of these chemokines remained high in mice that received CXCR2
antisera (data not shown).

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 11.
The effect of systemically administered antisera
against CXCR2 on neutrophil migration to the site of
Ehrlichia inoculation. Two groups of three BALB/c mice
were i.p. injected with antisera to CXCR2 or control sera prior to i.p.
Ehrlichia inoculation. Four hours later, peritoneal
lavage fluids from these mice were analyzed by flow cytometry by using
fluorescein isothiocyanate-labeled antibodies to Gr-1 molecule.
Peritoneal lavage neutrophil counts for these mice were compared with
counts for those that did not receive antisera or bacteria and those
that received only Ehrlichia sp. Results from one of two
representative studies are shown.
|
|
IL-8 levels in sera of patients with HGE.
IL-8 levels were
then determined in sera from patients with HGE, collected during a
surveillance study for ehrlichiosis in Connecticut (24).
Patients with HGE marked by fevers, myalgias, and/or headache and who
were PCR positive for the HGE agent in blood samples were considered to
be confirmed cases. Control sera were obtained from healthy individuals
and from persons who were enrolled in the surveillance study with
symptoms that were initially suggestive of HGE (fevers and myalgia) but
who did not have laboratory-based evidence of HGE (serology, PCR, or
morulae) (Fig. 12). Patients with
confirmed HGE had significantly higher levels of IL-8 than did the
control groups (P < 0.01). The two control groups had similar levels of IL-8.

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 12.
IL-8 levels in the sera of patients with HGE. HGE,
patients with confirmed HGE, based on the clinical history and PCR.
Control A, individuals who were clinically suspected of having HGE but
who did not have laboratory-based evidence (serology, PCR, or morulae)
of infection. Control B, healthy individuals. *, IL-8 levels were
significantly higher in patients with HGE than in individuals in
control group A or B (P < 0.02). Sera from five
individuals were examined in each group (HGE, control A, and control
B), and results are expressed as means ± standard errors.
|
|
 |
DISCUSSION |
These data demonstrate that the HGE agent induces IL-8 production
by host cells, which may then paradoxically help promote infection. The
results showing that ehrlichias induce IL-8 secretion are consistent
with recent data from Klein and colleagues (31) indicating
that several chemokines, including IL-8, monocyte chemotactic protein
1, macrophage inflammatory proteins 1
and 1
, and RANTES, were
produced by HL-60 cells and normal bone marrow cells in response to HGE
bacteria. We now show that peripheral neutrophils also secrete IL-8
upon infection with Ehrlichia sp. Our results further show
that IL-8 secretion is accompanied by upregulation of CXCR2, a receptor
for IL-8 on HL-60 cells. We also demonstrate that IL-8 is responsible
for the chemotaxis of naive neutrophils towards Ehrlichia
sp.-infected cells because neutrophil migration to infected cells can
be completely blocked with IL-8 antibodies. Moreover, the presence of
Ehrlichia DNA in the blood of patients with HGE correlated
with increased IL-8 levels, and Ehrlichia infection of
murine splenocytes induced high levels of neutrophil chemokines, MIP-2
and KC (the murine homologue for IL-8 has not yet been identified).
Given that the HGE agent survives in neutrophils, migration of
neutrophils towards the pathogen results in infection of the newly
recruited PMNs, or of their precursors, rather than the elimination of
bacteria. We further tested this hypothesis in vivo and demonstrated
that CXCR2
/
mice (9) or mice
administered CXCR2 antisera prior to Ehrlichia challenge are
less susceptible to infection with the HGE agent than are controls.
However, scid mice that were previously infected with
Ehrlichia sp. remained bacteremic after treatment with CXCR2 antisera, suggesting that neutrophil migration may not play a significant role in bacterial dissemination at this stage, since ehrlichias can continue to spread through the bloodstream. On the other
hand, during the initial stages of infection neutrophil propagation to
the site of inoculation may be important for the establishment of
infection. Indeed, i.p. inoculation of mice with Ehrlichia
sp. resulted in an increase in peritoneal KC and MIP-2 levels as well
as a neutrophilic influx. Moreover, administration of CXCR2 antisera
prior to Ehrlichia challenge of mice blocked the
neutrophilic migration to the peritoneal cavity. Decreased migration of
PMNs to the initial site of infection may have resulted in the
inhibition of systemic HGE infection in mice that received CXCR2
antisera before challenge with Ehrlichia sp.
Neutrophils are critical for the elimination of extracellular and
intracellular bacteria. Depletion of neutrophils with antibodies has
been shown previously to cause the death of mice infected with
sublethal doses of Escherichia coli, Listeria
monocytogenes, Staphylococcus aureus, or
Salmonella dublin (12, 20, 55, 56). Moreover,
the death of E. coli-infected mice deficient in
integrin-associated protein was associated with diminished neutrophil
migration (33). The role of CXCR2-mediated neutrophil migration in resistance to infection has been further addressed in
studies using neutralizing antibodies to murine CXCR2 or in CXCR2
/
mice. Administration of CXCR2
antibodies to mice resulted in decreased resistance to Nocardia
asteroides, Pseudomonas aeruginosa, and
Aspergillus spp. (39, 40, 54).
CXCR2
/
mice were also more susceptible to
gastric or systemic candidiasis after challenge with Candida
albicans than were control mice (4). Similarly, in
the absence of CXCR2, mice developed severe disease in an E. coli-induced urinary tract infection model while control mice did
not develop disease (16). These combined studies clearly demonstrated a role for IL-8 and CXCR2 in resistance to infection.
The tropism of Ehrlichia sp. for neutrophils is facilitated
by unique mechanisms. Ehrlichias use CD15s (19) and
P-selectin glycoprotein ligand 1 to invade neutrophils
(22). Once within the neutrophil, HGE bacteria then avoid
innate immune responses by residing in morulae that do not fuse with
lysosomes (42, 58) and by inhibiting the respiratory burst
(43) through downregulation of
gp91phox, a critical component of NADPH
oxidase (5). Ehrlichias may also partially inhibit
neutrophil apoptosis, thereby increasing the duration of survival
within the cell (60). Since Ehrlichia sp. is an
obligate intracellular pathogen, dissemination is dependent on timely
transfer of bacteria to naive neutrophils or neutrophil precursors. Our
results suggest that Ehrlichia sp. usurps the induction of
IL-8, a host chemokine, and its receptors to attract neutrophils or
neutrophil precursors and promote infection (Fig. 13).

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 13.
Schematic model for IL-8-facilitated
Ehrlichia dissemination. Host cell IL-8 secretion and
the surface expression of CXCR2 on neutrophils or their precursors are
induced by Ehrlichia sp. Ehrlichia sp.
orchestrates chemotaxis of uninfected neutrophils towards the infected
cells, thereby enhancing pathogen transmission. PSGL-1, P-selectin
glycoprotein ligand 1.
|
|
Recruitment of neutrophils by microorganisms that have evolved to
survive in phagocytic cells can be a model of dissemination for other
pathogens. A role for IL-8-mediated neutrophil chemotaxis in the spread
of cytomegalovirus has been suggested by Craigen and colleagues
(11). Cytomegalovirus induces IL-8 secretion from host
cells (11), and neutrophils play a major role in viral dissemination throughout the body (51). Furthermore, the
addition of IL-8 to cytomegalovirus-infected cells increases the
production of infectious virus (44).
Bacterial products such as lipopolysaccharides (13),
Borrelia burgdorferi outer surface protein OspA
(41), listeriolysin O of L. monocytogenes
(28), and Shiga toxin (53) have been shown
elsewhere to activate neutrophils through induction of IL-8 secretion
from host cells. Our data now show that HGE-44 is capable of
stimulating IL-8 secretion from rHL-60 cells and from PMNs in a
dose-dependent manner. It is not known whether HGE-44 alone or various
members of this family of proteins are the sole bacterial products that
induce IL-8 secretion. Bacterial lipopolysaccharides are potent
IL-8-inducing molecules, but although the HGE bacterial membrane may
have characteristics consistent with gram-negative organisms
(46), there is at present no evidence of
lipopolysaccharide in HGE bacteria. Indeed, our experiments showed that
Ehrlichia sp. does not induce the secretion of
proinflammatory cytokines (TNF-
, IL-1
, and IL-1
) that are
typically associated with lipopolysaccharide stimulation of IL-8. It is
also noteworthy that none of the other human CXCR2 ligand molecules
that can be associated with IL-8 secretion during other infections were
increased during Ehrlichia infection (48, 59).
In summary, we have shown that infection with the HGE agent induces the
secretion of human IL-8 and upregulates expression of the CXCR2
receptor on host cells. HGE-44 is one of the ligands that contribute to
the generation of IL-8. The production of this chemokine is important
for Ehrlichia infectivity because Ehrlichia sp.-induced IL-8 results in neutrophil chemotaxis, and granulocytic ehrlichiosis is diminished in CXCR2
/
mice or
animals administered CXCR2 antisera. The HGE agent appears, therefore,
to paradoxically exploit the response of host IL-8, a chemokine
normally used for microbial eradication, to facilitate infection.
 |
ACKNOWLEDGMENTS |
This work was supported by grants from the National Institutes of
Health, the Mathers Foundation, and the Eshe Foundation and a gift from
SmithKline Beecham Biologicals. E. Fikrig is the recipient of a
Clinical Scientist Award in Translational Research from the Burroughs
Wellcome Fund.
We thank Rita Palmarozza and Debbie Beck for technical assistance and
Isabelle Coppens for her help in the preparation of the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: 608 Laboratory
of Clinical Investigation, Section of Rheumatology, Department of
Internal Medicine, Yale University School of Medicine, 333 Cedar St.,
New Haven, CT 06520-8031. Phone: (203) 785-2453. Fax: (203) 785-7053. E-mail: erol.fikrig{at}yale.edu.
Present address: Department of Biology, University of North
Carolina at Charlotte, Charlotte, NC 28823.
Editor:
J. D. Clements
 |
REFERENCES |
| 1.
|
Aguero-Rosenfeld, M. E.,
H. W. Horowitz,
G. P. Wormser,
D. F. McKenna,
J. Nowakowski,
J. Munoz, and J. S. Dumler.
1996.
Human granulocytic ehrlichiosis: a case series from a medical center in New York State.
Ann. Intern. Med.
125:904-908[Abstract/Free Full Text].
|
| 2.
|
Akkoyunlu, M., and E. Fikrig.
2000.
Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia.
Infect. Immun.
68:1827-1833[Abstract/Free Full Text].
|
| 3.
|
Bakken, J. S.,
S. A. Erlemeyer,
R. J. Kanoff,
T. C. Silvestrini,
D. D. Goodwin, and J. S. Dumler.
1998.
Demyelinating polyneuropathy associated with human granulocytic ehrlichiosis.
Clin. Infect. Dis.
27:1323-1324[Medline].
|
| 4.
|
Balish, E.,
R. D. Wagner,
A. Vazquez-Torres,
J. Jones-Carson,
C. Pierson, and T. Warner.
1999.
Mucosal and systemic candidiasis in IL-8Rh-/- BALB/c mice.
J. Leukoc. Biol.
66:144-150[Abstract].
|
| 5.
|
Banerjee, R.,
J. Anguita,
D. Roos, and E. Fikrig.
2000.
Infection by the agent of human granulocytic ehrlichiosis prevents the respiratory burst by down-regulating gp91phox.
J. Immunol.
164:3946-3949[Abstract/Free Full Text].
|
| 6.
|
Behl, R.,
M. B. Klein,
L. Dandelet,
R. R. Bach,
J. L. Goodman, and N. S. Key.
2000.
Induction of tissue factor procoagulant activity in myelomonocytic cells inoculated by the agent of human granulocytic ehrlichiosis.
Thromb. Haemostasis
83:114-118[Medline].
|
| 7.
|
Belongia, E. A.,
K. D. Reed,
P. D. Mitchell,
P. H. Chyou,
N. Mueller-Rizner,
M. F. Finkel, and M. E. Schriefer.
1999.
Clinical and epidemiological features of early Lyme disease and human granulocytic ehrlichiosis in Wisconsin.
Clin. Infect. Dis.
29:1472-1477[CrossRef][Medline].
|
| 8.
|
Bunnell, J. E.,
E. R. Trigiani,
S. R. Srinivas, and J. S. Dumler.
1999.
Development and distribution of pathologic lesions are related to immune status and tissue deposition of human granulocytic ehrlichiosis agent-infected cells in a murine model system.
J. Infect. Dis.
180:546-550[CrossRef][Medline].
|
| 9.
|
Cacalano, G.,
J. Lee,
K. Kikly,
A. M. Ryan,
S. Pitts-Meek,
B. Hultgren,
W. I. Wood, and M. W. Moore.
1994.
Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog.
Science
265:682-684[Abstract/Free Full Text].
|
| 10.
|
Chuntharapai, A., and K. J. Kim.
1995.
Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor.
J. Immunol.
155:2587-2594[Abstract].
|
| 11.
|
Craigen, J. L.,
K. L. Yong,
N. J. Jordan,
L. P. MacCormac,
J. Westwick,
A. N. Akbar, and J. E. Grundy.
1997.
Human cytomegalovirus infection up-regulates interleukin-8 gene expression and stimulates neutrophil transendothelial migration.
Immunology
92:138-145[CrossRef][Medline].
|
| 12.
|
Czuprynski, C. J.,
J. F. Brown,
N. Maroushek,
R. D. Wagner, and H. Steinberg.
1994.
Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection.
J. Immunol.
152:1836-1846[Abstract].
|
| 13.
|
DeForge, L. E.,
J. S. Kenney,
M. L. Jones,
J. S. Warren, and D. G. Remick.
1992.
Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies.
J. Immunol.
148:2133-2141[Abstract].
|
| 14.
|
Denney, C. F.,
L. Eckmann, and S. L. Reed.
1999.
Chemokine secretion of human cells in response to Toxoplasma gondii infection.
Infect. Immun.
67:1547-1552[Abstract/Free Full Text].
|
| 15.
|
Dumler, J. S., and J. S. Bakken.
1998.
Human ehrlichiosis: newly recognized infections transmitted by ticks.
Annu. Rev. Med.
49:201-213[CrossRef][Medline].
|
| 16.
|
Frendeus, B.,
G. Godaly,
L. Hang,
D. Karpman,
A. C. Lundstedt, and C. Svanborg.
2000.
Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart.
J. Exp. Med.
192:881-890[Abstract/Free Full Text].
|
| 17.
|
Gewirtz, A. T.,
A. S. Rao,
P. O. Simon, Jr.,
D. Merlin,
D. Carnes,
J. L. Madara, and A. S. Neish.
2000.
Salmonella typhimurium induces epithelial IL-8 expression via Ca(2+)-mediated activation of the NF-kappaB pathway.
J. Clin. Investig.
105:79-92[Medline].
|
| 18.
|
Goodman, J. L.,
C. Nelson,
B. Vitale,
J. E. Madigan,
J. S. Dumler,
T. J. Kurtti, and U. G. Munderloh.
1996.
Direct cultivation of the causative agent of human granulocytic ehrlichiosis.
N. Engl. J. Med.
334:209-215[Abstract/Free Full Text].
|
| 19.
|
Goodman, J. L.,
C. M. Nelson,
M. B. Klein,
S. F. Hayes, and B. W. Weston.
1999.
Leukocyte infection by the granulocytic ehrlichiosis agent is linked to expression of a selectin ligand.
J. Clin. Investig.
103:407-412[Medline].
|
| 20.
|
Haraoka, M.,
L. Hang,
B. Frendeus,
G. Godaly,
M. Burdick,
R. Strieter, and C. Svanborg.
1999.
Neutrophil recruitment and resistance to urinary tract infection.
J. Infect. Dis.
180:1220-1229[CrossRef][Medline].
|
| 21.
|
Hardalo, C. J.,
V. Quagliarello, and J. S. Dumler.
1995.
Human granulocytic ehrlichiosis in Connecticut: report of a fatal case.
Clin. Infect. Dis.
21:910-914[Medline].
|
| 22.
|
Herron, M. J.,
C. M. Nelson,
J. Larson,
K. R. Snapp,
G. S. Kansas, and J. L. Goodman.
2000.
Intracellular parasitism by the human granulocytic ehrlichiosis bacterium through the P-selectin ligand, PSGL-1.
Science
288:1653-1656[Abstract/Free Full Text].
|
| 23.
|
Hodzic, E.,
J. W. Ijdo,
S. Feng,
P. Katavolos,
W. Sun,
C. H. Maretzki,
D. Fish,
E. Fikrig,
S. R. Telford, and S. W. Barthold.
1998.
Granulocytic ehrlichiosis in the laboratory mouse.
J. Infect. Dis.
177:737-745[Medline].
|
| 24.
|
Ijdo, J. W.,
J. I. Meek,
M. L. Cartter,
L. A. Magnarelli,
C. Wu,
S. W. Tenuta,
E. Fikrig, and R. W. Ryder.
2000.
The emergence of another tickborne infection in the 12-town area around Lyme, Connecticut: human granulocytic ehrlichiosis.
J. Infect. Dis.
181:1388-1393[CrossRef][Medline].
|
| 25.
|
Ijdo, J. W.,
W. Sun,
Y. Zhang,
L. A. Magnarelli, and E. Fikrig.
1998.
Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response.
Infect. Immun.
66:3264-3269[Abstract/Free Full Text].
|
| 26.
|
Ijdo, J. W.,
C. Wu,
L. A. Magnarelli, and E. Fikrig.
1999.
Serodiagnosis of human granulocytic ehrlichiosis by a recombinant HGE-44-based enzyme-linked immunosorbent assay.
J. Clin. Microbiol.
37:3540-3544[Abstract/Free Full Text].
|
| 27.
|
Jahangir, A.,
C. Kolbert,
W. Edwards,
P. Mitchell,
J. S. Dumler, and D. H. Persing.
1998.
Fatal pancarditis associated with human granulocytic ehrlichiosis in a 44-year-old man.
Clin. Infect. Dis.
27:1424-1427[Medline].
|
| 28.
|
Kayal, S.,
A. Lilienbaum,
C. Poyart,
S. Memet,
A. Israel, and P. Berche.
1999.
Listeriolysin O-dependent activation of endothelial cells during infection with Listeria monocytogenes: activation of NF-kappa B and upregulation of adhesion molecules and chemokines.
Mol. Microbiol.
31:1709-1722[CrossRef][Medline].
|
| 29.
|
Kim, H. Y., and Y. Rikihisa.
1998.
Characterization of monoclonal antibodies to the 44-kilodalton major outer membrane protein of the human granulocytic ehrlichiosis agent.
J. Clin. Microbiol.
36:3278-3284[Abstract/Free Full Text].
|
| 30.
|
Kim, H. Y., and Y. Rikihisa.
2000.
Expression of interleukin-1 , tumor necrosis factor alpha, and interleukin-6 in human peripheral blood leukocytes exposed to human granulocytic ehrlichiosis agent or recombinant major surface protein P44.
Infect. Immun.
68:3394-3402[Abstract/Free Full Text].
|
| 31.
|
Klein, M. B.,
S. Hu,
C. C. Chao, and J. L. Goodman.
2000.
The agent of human granulocytic ehrlichiosis induces the production of myelosuppressing chemokines without induction of proinflammatory cytokines.
J. Infect. Dis.
182:200-205[CrossRef][Medline].
|
| 32.
|
Klein, M. B.,
J. S. Miller,
C. M. Nelson, and J. L. Goodman.
1997.
Primary bone marrow progenitors of both granulocytic and monocytic lineages are susceptible to infection with the agent of human granulocytic ehrlichiosis.
J. Infect. Dis.
176:1405-1409[Medline].
|
| 33.
|
Lindberg, F. P.,
D. C. Bullard,
T. E. Caver,
H. D. Gresham,
A. L. Beaudet, and E. J. Brown.
1996.
Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice.
Science
274:795-798[Abstract/Free Full Text].
|
| 34.
|
Luzza, F.,
T. Parrello,
G. Monteleone,
L. Sebkova,
M. Romano,
R. Zarrilli,
M. Imeneo, and F. Pallone.
2000.
Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa.
J. Immunol.
165:5332-5337[Abstract/Free Full Text].
|
| 35.
|
Mahalingam, S., and G. Karupi |